Cuervas-Mons V - Search Results

1

TT genotype of transforming growth factor beta1 +869C/T is associated with the development of chronic kidney disease after liver transplantation.

Cuenca AB, Citores MJ, de la Fuente S, Duca AM, Escamilla N, Baños I, Cuervas-Mons V. Cuenca AB, et al. Transplant Proc. 2014 Nov;46(9):3108-10. doi: 10.1016/j.transproceed.2014.10.002. Transplant Proc. 2014. PMID: 25420836

2

Interleukin-28B TT genotype is frequently found in patients with hepatitis C virus cirrhosis but does not influence hepatocarcinogenesis.

de la Fuente S, Citores MJ, Duca A, Cisneros E, Baños I, Vilches C, Cuervas-Mons V. de la Fuente S, et al. Clin Exp Med. 2017 May;17(2):217-223. doi: 10.1007/s10238-016-0418-1. Epub 2016 Apr 15. Clin Exp Med. 2017. PMID: 27083168

3

Rapidity of fibrosis progression in liver transplant recipients with recurrent hepatitis C is influenced by toll-like receptor 3 polymorphism.

Citores MJ, Pérez-Pulgar S, Duca A, Crespo G, de la Fuente S, Vilches C, Navasa M, Cuervas-Mons V. Citores MJ, et al. Clin Transplant. 2016 Jul;30(7):810-8. doi: 10.1111/ctr.12754. Epub 2016 May 23. Clin Transplant. 2016. PMID: 27101936

4

Increased risk of severe hepatitis C virus recurrence after liver transplantation in patients with a T allele of IL28B rs12979860.

Cisneros E, Baños I, Citores MJ, Duca A, Salas C, Noblejas A, Cañizares M, Millán I, Cuervas-Mons V, Vilches C. Cisneros E, et al. Transplantation. 2012 Aug 15;94(3):275-80. doi: 10.1097/TP.0b013e31825668f6. Transplantation. 2012. PMID: 22790387

5

Toll-like receptor 3 L412F polymorphism may protect against acute graft rejection in adult patients undergoing liver transplantation for hepatitis C-related cirrhosis.

Citores MJ, Baños I, Noblejas A, Rosado S, Castejon R, Cuervas-Mons V. Citores MJ, et al. Transplant Proc. 2011 Jul-Aug;43(6):2224-6. doi: 10.1016/j.transproceed.2011.05.011. Transplant Proc. 2011. PMID: 21839239

6

Long-term survivors after pediatric liver transplatation are at increased risk for development of cardiovascular disease events: analysis of 30 cases.

de la Fuente S, Citores MJ, Baños I, Duca A, Cuervas-Mons V. de la Fuente S, et al. Transplant Proc. 2014 Nov;46(9):3111-3. doi: 10.1016/j.transproceed.2014.10.003. Transplant Proc. 2014. PMID: 25420837

7

CC genotype at rs12979860 of IL28B is associated with lower risk of new-onset diabetes after transplantation in adult patients with liver transplantation for hepatitis C cirrhosis.

Duca AM, de la Fuente S, Citores MJ, Cuenca AB, Cisneros E, Escamilla N, Baños I, Vilches C, Cuervas-Mons V. Duca AM, et al. Transplant Proc. 2014 Nov;46(9):3114-6. doi: 10.1016/j.transproceed.2014.10.004. Transplant Proc. 2014. PMID: 25420838

8

Drug-Induced Lung Injury in a Liver Transplant Patient Treated With Sofosbuvir.

Benítez-Gutiérrez L, de Mendoza C, Baños I, Duca A, Arias A, Treviño A, Requena S, Citores MJ, Cuervas-Mons V. Benítez-Gutiérrez L, et al. Transplant Proc. 2016 Sep;48(7):2515-2518. doi: 10.1016/j.transproceed.2016.08.026. Transplant Proc. 2016. PMID: 27742338

9

Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation.

Citores MJ, Lucena JL, de la Fuente S, Cuervas-Mons V. Citores MJ, et al. World J Hepatol. 2019 Jan 27;11(1):50-64. doi: 10.4254/wjh.v11.i1.50. World J Hepatol. 2019. PMID: 30705718 Free PMC article. Review.

10

TLR9-1486C/T polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation.

de la Fuente S, Citores MJ, Lucena JL, Muñoz P, Cuervas-Mons V. de la Fuente S, et al. Biomark Med. 2019 Aug;13(12):995-1004. doi: 10.2217/bmm-2019-0030. Epub 2019 Jul 18. Biomark Med. 2019. PMID: 31317790

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters